Name (Synonyms) | Correlation | |
---|---|---|
D007239 | Infection NIH | 0.06 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The purpose of this study is to investigate the potential use of Wharton's Jelly Mesenchymal stem cells (WJ-MSCs) for treatment of patient diagnosed with Corona Virus SARS-CoV-2 infection, and showing symptoms of COVID-19.
Description: Improvement of clinical symptoms including duration of fever, respiratory destress, pneumonia, cough, sneezing, diarrhea.
Measure: Clinical outcome Time: 3 weeksDescription: Side effects measured by Chest Readiograph
Measure: CT Scan Time: 3 weeksDescription: Results of Real-Time Polymerase Chain Reaction of Viral RNA, Turing negative
Measure: RT-PCR results Time: 3 weeksDescription: Results of Real-Time Polymerase Chain Reaction of Viral RNA, Turing negative
Measure: RT-PCR results Time: 8 weeks